Arash Hatefi
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 23, 2024
A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide.Ge Yang, Shahryar Khoshtinat Nikkhoi, Hajar Owji
|Mar 15, 2024
Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice.Shahryar Khoshtinat Nikkhoi, Ge Yang, Hajar Owji
|Aug 26, 2023
A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab's epitope with versatile biochemical, biological, and medical applications.Shahryar Khoshtinat Nikkhoi, Hediyeh Heydarzadeh, Venu Gopal Vandavasi
|Mar 02, 2023
Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands.Geng Li, Shahryar Khoshtinat Nikkhoi, Arash Hatefi
|Jun 22, 2018
A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer.Siddik Sarkar, Obeid M Malekshah, Alireza Nomani
|Aug 15, 2017
Development of a Recombinant Multifunctional Biomacromolecule for Targeted Gene Transfer to Prostate Cancer Cells.Arash Hatefi, Zahra Karjoo, Alireza Nomani
Pageof 1
